PatientsLikeMe ™

all
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Combivent, DuoNeb, DuoNeb w/nebulizer

What is Ipratropium and albuterol? Bronchodilator that contains ipratropium bromide and albuterol sulfate and is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).


Reasons Taken

20 patients in the community are taking or have taken Ipratropium and albuterol.

Reason # Patients Percentage of patients
Other 12 60%
General health 2 10%
Asthma 2 10%
Excess saliva 1 5%
disease-related symptoms 1 5%
Breathing difficulty 1 5%
Slow my ALS progress 1 5%

Dosages

Based on the patients currently taking Ipratropium and albuterol.

Top 10 (Show all)

All (Show Top 10)

  0 mcg day 0 mL day 0 mcg none 0 mg none 0 mL none 0 none 0.5 mg day 2 mcg day 2 day 3 other day 4 other day 5 mg day 10 mg day 12 mg day 360 mcg day 29400 mcg day
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Ipratropium and albuterol or how long patients were taking Ipratropium and albuterol before stopping.

Currently taking Ipratropium and albuterol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
1
1
2
1
5

Stopped taking Ipratropium and albuterol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
0
0
Why Patients Stopped Taking Ipratropium and albuterol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1 100% Other: 100%


Back to top